Clinical Research Solutions

Data Integrity 101: Is your data compliant?

Data integrity has recently been in the agency spotlight. In part because of the draft data integrity guidance issued April 2016, but primarily due to an increased number of inspection findings...

Clinical Research Solutions

Clinical Quality Systems & the Outsourced Model

The landscape of clinical trials is evolving. The changes that are happening are due to the increased number of FDA-regulated trials, as well as a rise in the complexity of clinical protocols. As...

Clinical Research Solutions

FDA’s Most Frequent 483 Observations for 2016: A Reflection of Industry’s Compliance

At the beginning of each year, the US FDA posts the previous year’s Form 483 observation metrics issued by each product center. Image Source: FDA I find that reviewing these metrics provides a...

Clinical Research Solutions

The Benefits of Process Characterization in Process Development

The desire for a robust and repeatable manufacturing process is shared by every organization that has a therapy or product in development and the only way to demonstrate that this desired state has...

Regulatory Sciences

Submitting Initial Pediatric Study Plans and Amended Initial Pediatric Study Plans

On March 8, 2016, the FDA announced availability of a revised draft guidance for industry regarding pediatric study plans, entitled "Pediatric Study Plans: Content of and Process for Submitting...

#5: How to Comply with the Pediatric Research Equity Act

On September 7, 2005, FDA announced the availability of a draft guidance, entitled "How to Comply with the Pediatric Research Equity Act," providing sponsors with a number of recommendations...

Quality & Compliance

The Investigation Best Practices to Avoid FDA 483 Observations

For a number of years, discrepancy and failure investigations within the pharmaceutical industry have been populating the Top 3 of a Food and Drug Administration (FDA) Observation list....

Clinical Research Solutions

#10: Investigator Responsibilities – Protecting the Rights, Safety, & Welfare of Study Subjects

In October 2009, the FDA issued a guidance document regarding its expectations for investigators during the conduct of clinical investigations. The guidance, entitled Investigator...

Clinical Research Solutions

Top Ten FDA Guidance Documents That You Should Know

There are a number of laws, regulations, and guidance documents ruling the pharmaceutical and biotechnology industries. Laws are passed by Congress and must be followed by the FDA. The Agency then...

Is Your Laboratory PC Cloned From the Proper Image?

Managing compliance for computerized lab systems includes the PC controlling your qualified instruments. This is an integral audit point that must be maintained to ensure compliance. Ah, but you’re...

Clinical Research Solutions

How critical is the Technology Transfer phase of new drug development?

During the development phase of a new drug, great pains are taken to characterize the molecule and to run a myriad of laboratory and animal tests to determine the product attributes, toxicology...

Clinical Research Solutions

Does Your Training Program Have Traction?

With the spotlight these days on Data Integrity, it may be easy to lose sight of some fundamental Quality Systems. Core Quality Systems include Document Management, Investigation Management, and...

Clinical Research Solutions

How Much Can You Afford NOT to Know?

The Regulatory Guidance embodied by ICHQ8 through (soon to be written) ICHQ12 tells us in no uncertain terms that we must protect the patient across the product lifecycle by assuring quality based on...

Problem Solving: What’s the Best Approach?

Those of you in the pharmaceutical, biotech and medical device industries who encounter process and product problems on a regular basis, you likely grimace when one lands in your lap. There is a...

Clinical Research Solutions

Quick Guide: cGMP for Phase 1 Investigational Drugs

As Phase I clinical trials mark the first time that an investigational new drug is administered to humans, these studies are subject to appropriate current Good Manufacturing Practices (cGMP) in...

Clinical Research Solutions

Does your Quality System stand up to the challenge?

Implementing and maintaining a Quality System is a complex challenge. It is as much as an art as it is a science. A company’s Quality System establishes the framework to manage and maintain...